Working Group: Restructure NCI, Improve Review Process, Encourage Independence
In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb
“Significant changes should be made to reduce redundancy, streamline operations, promote collaboration, and optimize productivity.”
“Perhaps the most troubling finding was a broad dissatisfaction with the general ethos within the intramural community.”
Trending Stories
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine - Understanding the impact of the Israeli-U.S. attacks on Iran’s nuclear facilities